Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular injury" refers to damage or trauma to blood vessels—arteries, veins, or lymphatics—caused by external force such as blunt impact, penetrating wounds, or medical procedures. It is not a single molecule, receptor, enzyme, transporter, or other canonical drug target but rather a pathological condition. Vascular injuries can result in bleeding (hemorrhage), thrombosis (clotting), ischemia (loss of blood supply), and may lead to serious complications including limb loss or death if not promptly managed. The term encompasses both penetrating injuries (e.g., stab wounds) and nonpenetrating injuries (e.g., crush injuries). Management focuses on restoring perfusion and controlling bleeding rather than targeting a specific molecular entity[2][5][8].\n\nNote: "Vascular injury" does not refer to a discrete molecular target but describes a clinical event/condition; therefore it cannot be mapped onto structured fields for drug targets such as receptors or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular injury.